We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

39 hedge funds and large institutions have $119M invested in Cytokinetics in 2013 Q2 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+39
Holders Change %
–
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
39
Increased
–
Reduced
–
Closed
–
Calls
$4.57M
Puts
–
Net Calls
+$4.57M
Net Calls Change
+$4.57M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$379K +$258K +32,727 New
IAM
27
Impax Asset Management
New Hampshire
$328K +$223K +28,333 New
CC
28
Curian Capital
Colorado
$323K +$220K +27,916 New
TCM
29
Texan Capital Management
Texas
$245K +$167K +21,219 New
MLICM
30
Metropolitan Life Insurance Company (MetLife)
New York
$238K +$162K +20,612 New
Citigroup
31
Citigroup
New York
$219K +$149K +18,971 New
EWM
32
Evercore Wealth Management
New York
$196K +$133K +16,914 New
PAM
33
Panagora Asset Management
Massachusetts
$185K +$126K +16,022 New
HCM
34
Highbridge Capital Management
New York
$167K +$114K +14,448 New
AL
35
Airain Ltd
Guernsey
$142K +$96.5K +12,249 New
FAM
36
Fortaleza Asset Management
Illinois
$137K +$93K +11,804 New
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$121K +$82.7K +10,500 New
Ameriprise
38
Ameriprise
Minnesota
$18K +$12.2K +1,544 New
HNB
39
Huntington National Bank
Ohio
$1K +$835 +106 New
1
2

CYTK Hedge Fund Activity: Q2 2013 in Review

39 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q2 2013, worth a combined $119M.

Buyers outnumbered sellers: 39 funds opened new CYTK positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.

  • 39 institutional investors held Cytokinetics (CYTK) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $119M of Cytokinetics stock for Q2 2013.
  • 39 funds opened new Cytokinetics positions in Q2 2013 and 0 closed out, a net change of +39 holders.

Based on aggregated 13F filings for Q2 2013.